0,1,2,3
Appendix A,,,
,Table A1. EBOV entry inhibitors and viral model systems used for their discovery.,,
Class &Compound,Viral Model,Validation with EBOV 1,Reference
Ion channel inhibitors,,,
Amiodarone,"RV, VSV, VLP",YES,[62â€“64]
Bepridil,"RV, VSV",YES,[69]
Dronedarone,RV,YES,[62]
Noricumazole A,"RV, VSV",N/A,[72]
Tetrandrine,VSV,YES,[33]
Verapamil,RV,YES,[62]
Antimicrobial agents,,,
Albendazole,VLP,N/A,[82]
Aminoquinoline,VSV,YES,[75]
Amodiaquine,VSV,YES,[75]
Azithromycin,VLP,N/A,[82]
Chloroquine,VSV,YES,[75]
Emetine,VLP,YES,[81]
Ferroquine,VLP,N/A,[79]
Hydroxychloroquine,VSV,YES,[75]
Mebendazole,VLP,N/A,[82]
Suramin,VSV,YES,[80]
Teicoplanin,"RV, VLP",N/A,"[83,84]"
Terconazole,"RV, VSV",YES,"[69,85]"
Triparanol,"RV, VSV",YES,[85]
Psychoactive drugs,,,
Benztropine,RV,YES,[88]
Chlorpromazine,RV,YES,[86]
Chlorcyclizine,RV,YES,[89]
Diphenhydramine,RV,YES,[89]
Diphenhylpyraline,VSV,YES,[75]
Imipramine,VSV,YES,[30]
Ketotifen,VSV,YES,[75]
Maprotiline,VLP,N/A,[82]
Promethazine,RV,YES,[88]
Sertraline,"RV, VSV",YES,[69]
Trimipramine,RV,YES,[88]
Selective estrogen receptor modulators,,,
Clomiphene,"VLP, VSV",YES,"[69,85,91]"
Toremifene,VLP,YES,"[69,91]"
Protein kinase inhibitors,,,
Apilimod,"RV, VLP",YES,[98]
Erlotinib,VSV,YES,[97]
Pyridinyl imidazole,VLP,YES,[100]
Sunitinib,VSV,YES,[97]
1-Benzyl-3-cetyl-2-methylimidazolium iodide,VSV,N/A,[103]
